Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/0886022X.2019.1707098 http://scihub22266oqcxt.onion/10.1080/0886022X.2019.1707098 31878817!6968512!31878817     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Ren+Fail 2020 ; 42 (1): 54-65 Nephropedia Template TP {{tp|p=31878817|t=2020. Acquired long QT syndrome in chronic kidney disease patients |pdf=|usr=}}{{31878817}} gab.com Text Acquired long QT syndrome in chronic kidney disease patients JO: Ren Fail http://www.kidney.de/pget.php?&tw=1&pmid=31878817 #FOAvip Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in chronic kidney disease (CKD) patients. QT interval prolongation is a congenital or acquired condition that is associated with an increased risk of torsade de pointes (TdP), sudden cardiac death (SCD), and all-cause mortality in the general population. The prevalence of acquired long QT syndrome (aLQTS) is high, and various acquired conditions contribute to the prolonged QT interval in patients with CKD. More notably, the prolonged QT interval in CKD is an independent risk factor for SCD and all-cause mortality. In this review, we focus on the epidemiological characteristics, risk factors, underlying mechanisms and treatments of aLQTS in CKD, promoting the management of aLQTS in CKD patients. Twit Text FOAVip Acquired long QT syndrome in chronic kidney disease patients ????Ren Fail http://www.kidney.de/pget.php?&tw=1&pmid=31878817 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=31878817 #FOAvip English Wikipedia <ref>{{Cite pmid|31878817}}</ref> Acquired long QT syndrome in chronic kidney disease patients #MMPMID31878817 Liu P; Wang L; Han D; Sun C; Xue X; Li G Ren Fail 2020[Nov]; 42 (1): 54-65 PMID31878817show ga Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in chronic kidney disease (CKD) patients. QT interval prolongation is a congenital or acquired condition that is associated with an increased risk of torsade de pointes (TdP), sudden cardiac death (SCD), and all-cause mortality in the general population. The prevalence of acquired long QT syndrome (aLQTS) is high, and various acquired conditions contribute to the prolonged QT interval in patients with CKD. More notably, the prolonged QT interval in CKD is an independent risk factor for SCD and all-cause mortality. In this review, we focus on the epidemiological characteristics, risk factors, underlying mechanisms and treatments of aLQTS in CKD, promoting the management of aLQTS in CKD patients. |Anti-Arrhythmia Agents/therapeutic use[MESH] |Cardiac Pacing, Artificial/methods[MESH] |Death, Sudden, Cardiac/*epidemiology/etiology[MESH] |Electrocardiography[MESH] |Graft Rejection/immunology/prevention & control[MESH] |Heart Rate/drug effects[MESH] |Humans[MESH] |Immunosuppressive Agents/adverse effects[MESH] |Kidney Transplantation/adverse effects[MESH] |Long QT Syndrome/diagnosis/*epidemiology/etiology/therapy[MESH] |Prevalence[MESH] |Renal Dialysis/adverse effects[MESH] |Renal Insufficiency, Chronic/*complications/mortality/therapy[MESH] |Review Literature as Topic[MESH]Acquired long QT syndrome in chronic kidney disease patients (epmc).pdf DeepDyve Pubget Overpricing